ABOUT THE JOURNAL

Aims and scope of journal
Impact factor
Abstracted/indexed in
ISSN and eISSN
Editors

Top

Aims and scope of journal

Gene Therapy covers both the research and clinical applications of the new genetic therapy techniques currently being developed. The application of molecular biology has revolutionised our understanding of many diseases and has been readily applied for diagnostic purposes. Over the last decade, gene therapy protocols have entered clinical trials in increasing numbers. Covering a wide spectrum of diseases, these studies promise to unite the diverse organ based specialities into which modern medicine has become divided. Gene Therapy covers all aspects of gene therapy as applied to human disease, including preclinical animal experiments, novel platform technologies for gene transfer, and gene expression analysis.

Top

Impact Factor

2006 Impact Factor: 4.782*

Rank:
9/76 Medicine, Research & Experimental
15/140 Biotechnology and Applied Microbiology
25/131 Genetics & Heredity
57/262 Biochemistry & Molecular Biology

* Journal Citation Reports, Thomson 2007

Top

Abstracted/indexed in

BIOBASE/Current Awareness in Biological Sciences
Biotechnology Citation Index
Chemical Abstracts
Current Contents
Current Contents/Life Sciences
Derwent's Biotechnology Abstracts
Derwent's Gene Therapy Database
EMBASE/Excerpta Medica
MEDLINE/Index Medicus
MEDLARS
Science Citation Index

Top

ISSN and eISSN

The international standard serial number (ISSN) for Gene Therapy is 0969-7128 and the electronic international standard serial number (eISSN) is 1476-5462.

Top

Editors

USA Editor

J Glorioso, USA

European Editor

N Lemoine, UK

Associate Editors

E Alton, UK
P Robbins, USA
D Valerio, The Netherlands
H Tahara, Japan
D Curiel, USA

Editorial Board

SM Albelda, USA
R Alemany, Spain
S Aliño, Spain
C Baum, Germany
J-P Behr, France
T Blankenstein, Germany
DM Bodine, USA
X O Breakefield, USA
M Brenner, USA
J Bubenik, Czech Republic
X Cao, China
MC Capogrossi, Italy
M G Castro, UK
RB Cattaneo, USA
J Chamberlain, USA
Y Chernajovsky, UK
WH Colledge, UK
MKL Collins, UK
M Conese, Italy
K Cornetta, USA
C Coutelle, UK
RG Crystal, USA
O Danos, France
B Davidson, USA
KE Davies, UK
RJ Debs, USA
ML Degos, France
N DeLuca, USA
J Dick, Canada
S Eck, USA
L Eisenbach, Israel
C Evans, USA
F Farzaneh, UK
MC Favrot, France
HJ Federoff, USA
D Fink, USA
TR Flotte, USA
J Fujimoto, Japan
F Gage, USA
W Goins, USA
J M Goldman, UK
B Groner, Germany
D Gruenert, USA
WH Guenzburg, Austria
R E Hawkins, UK
EP Hoffman, USA
L Huang, USA
MJ Imperiale, USA
M Kay, USA
HP Kiem, USA
S Kim, Korea
SM Kingsman, UK
C Kinnon, UK
DH Kirn,
R Kotin, USA
DW Kufe, USA
J Leiden, USA
AML Lever, UK
PR Lowenstein, USA
L Luzzatto, Italy
RS McIvor, USA
AD Miller, USA
PA Morel, USA
R Morgan, USA
JD Mountz, USA
R Mulligan, USA
N Muzyczka, USA
GJ Nabel, USA
L Naldini, Italy
BW O'Malley, USA
W Ostertag, Germany
G Palu, Italy
M Perricaudet, France
DJ Porteous, UK
SD Rabkin, USA
S Raper, USA
C Reis e Sousa, UK
B Roizman, USA
SJ Russell, USA
M Sadelain, USA
J Samulski, USA
PF Searle, UK
LW Seymour, UK
K Sikora, UK
A Smith, USA
CJ Springer, UK
A Srivastava, USA
G Stamatoyannopoulos, USA
FC Szoka Jr, USA
MA Vega, Argentina
RG Vile, UK
EK Wagner, USA
DJ Wells, UK
RJ Whitley, USA
TJ Wickham, USA
R Williamson, Australia
JM Wilson, USA
JH Wolfe, USA
JA Wolff, USA
SLC Woo, USA
X Xiao, USA
S Ylä-Herttuala, Finland
L Young, UK

Extra navigation

.

naturejobs

natureproducts


ADVERTISEMENT